Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6251913 | 7037977 | I | 6251913-X | 20090526 | 20090617 | 20090630 | EXP | JP-ELI_LILLY_AND_COMPANY-JP200906005376 | ELI LILLY AND COMPANY | 54 | YR | F | Y | 20090629 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6251913 | 1011817776 | PS | ZYPREXA | 1 | OTHER | 20 MG, DAILY (1/D) | 020592 | ||||
| 6251913 | 1011817777 | C | BENZALIN | 2 | OTHER | 10 MG, DAILY (1/D) | |||||
| 6251913 | 1011817778 | C | LEVOTOMIN | 2 | OTHER | 50 MG, DAILY (1/D) | |||||
| 6251913 | 1011817779 | C | LINTON | 2 | INTRAVENOUS | 10 MG, DAILY (1/D) |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6251913 | 1011817776 | SCHIZOPHRENIA |
| 6251913 | 1011817777 | INSOMNIA |
| 6251913 | 1011817778 | SCHIZOPHRENIA |
| 6251913 | 1011817779 | SCHIZOPHRENIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6251913 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6251913 | DRUG ERUPTION |
| 6251913 | INTENTIONAL DRUG MISUSE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6251913 | 1011817776 | 20090526 | 20090528 | 3 | DAY |
| 6251913 | 1011817777 | 20090526 | |||
| 6251913 | 1011817778 | 20090526 | |||
| 6251913 | 1011817779 | 20090526 |